Search News Archives
Special Offers and Promotions
Brochures & Literature
Conferences | Events
Secure Maximum Protein Stability with BioVision’s Prionex
Proteins are seldom stable outside of their native environments and tend to lose activity due to proteolysis, aggregation, etc. To counter this phenomenon and increase their shelf life, different compounds are routinely used as additives.
This problem however is even more pronounced in dilute protein solutions which need the additional support of carrier proteins to help them survive the non-native storage conditions. The most commonly used carrier protein is purified Bovine serum Albumin (BSA). However, different experimental requirements warrant the use of alternative carrier proteins.
BioVision has introduced Prionex® as a very effective and cheap alternative to BSA for this very purpose. Prionex® is isolated from porcine dermal collagen and is available in a liquid form for easy addition to any protein solution.
Due to its chemical nature and the standardized quality, Prionex® can be used for multiple purposes like:
- Inert protein stabilizer in many applications.
- Protective additive in cell culture.
- Blocking agent.
Salient features of BioVision’s Prionex®:
- Non-toxic and non-antigenic.
- Filterable through a 0.2 µm membrane.
- Minimal endotoxin levels.
- Free from nucleic acids, polysaccharides and lipids.
- Free from any additives.
- No risk of BSE, MCD and HIV infective agents.
get 15% off on all BioVision proteins! Coupon code: BV15ANN. U.S. customers only. Cannot be combined with any other offers.
BioVision, Inc. is a privately held Life Science company headquartered in the beautiful San Francisco Bay area. BioVision develops and offers a wide variety of products including assay kits, antibodies, recombinant proteins & enzymes, and other innovative research tools for studying Apoptosis, Metabolism, Cell Proliferation, Cellular Stress, Cell Damage and Repair, Diabetes, Obesity and Metabolic Syndrome, Stem Cell Biology, Gene Regulation, Signal Transduction, and more.